Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways

Journal of Experimental and Clinical Cancer Research

Volumn 35, Issue 1, 2016, Pages

  Wan, Jun ^a   Wu, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis potential; Cd34; Extracellular regulated protein kinases (erk); Hyperthermia; Hypoxia inducible factor 1 alpha (hif 1a); Non small cell lung cancer (NSCLC); Protein kinase b (akt); Signaling pathway protein; Small cell lung cancer (sclc); Tumor proliferation

Indexed keywords

CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; WORTMANNIN; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; FLAVONOID; HIF1A PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER RECURRENCE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CANCER CELL LINE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TEMPERATURE; THERMOTHERAPY; TUMOR GROWTH; TUMOR VASCULARIZATION; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; LUNG TUMOR; MAPK SIGNALING; METABOLISM; MOUSE; NON SMALL CELL LUNG CANCER; PHOSPHORYLATION; PROCEDURES; SMALL CELL LUNG CANCER; TUMOR CELL LINE; TUMOR RECURRENCE; VASCULARIZATION;

ANDROSTADIENES; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERTHERMIA, INDUCED; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM RECURRENCE, LOCAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SMALL CELL LUNG CARCINOMA;

EID: 84979503137     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-016-0399-7     Document Type: Article

References (35)

1. Wang Y, Li G, Li W, He X, Xu L. Radiofrequency ablation of advanced lung tumors: imaging features, local control, and follow-up protocol. Int J Clin Exp Med. 2015;8(10):18137-43.
2. Wan J, Wu W, Chen Y, Kang N, Zhang R. Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1alpha signals. Acta Biochim Biophys Sin (Shanghai). 2016;48(4):371-7.
3. Yang J, Zhang X, Zhang Y, Zhu D, Zhang L, Li Y, et al. HIF-2alpha promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer. J Exp Clin Cancer Res. 2016;35:26.
4. Zhang J, Zhu L, Fang J, Ge Z, Li X. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1alpha activation. J Exp Clin Cancer Res. 2016;35:29.
5. Wan J, Ma J, Mei J, Shan G. The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells. J Exp Clin Cancer Res. 2009;28:150.
6. Wan J, Chai H, Yu Z, Ge W, Kang N, Xia W, et al. HIF-1alpha effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res. 2011;30:77.
7. Fan LF, Diao LM, Chen DJ, Liu MQ, Zhu LQ, Li HG, et al. Expression of HIF-1 alpha and its relationship to apoptosis and proliferation in lung cancer. Ai Zheng. 2002;21(3):254-8.
8. Swinson DE, O'Byrne KJ. Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer. Clin Lung Cancer. 2006;7(4):250-6.
9. Wan J, Wu W, Zhang R. Local recurrence of small cell lung cancer following radiofrequency ablation is induced by HIF1alpha expression in the transition zone. Oncol Rep. 2016;35(3):1297-308.
10. Zhang QL, Cui BR, Li HY, Li P, Hong L, Liu LP, et al. MAPK and PI3K pathways regulate hypoxia-induced atrial natriuretic peptide secretion by controlling HIF-1 alpha expression in beating rabbit atria. Biochem Biophys Res Commun. 2013;438(3):507-12.
11. Agani F, Jiang BH. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets. 2013;13(3):245-51.
12. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, et al. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell. 2007;18(12):4691-7.
13. Dent P. ERK plays the baddie (again). Cancer Biol Ther. 2013;14(11):997-8.
14. Klement GL, Goukassian D, Hlatky L, Carrozza J, Morgan JP, Yan X. Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart. Front Pharmacol. 2012;3:113.
15. Ren A, Qiu Y, Cui H, Fu G. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2015;459(1):10-7.
16. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 2005;24(36):5552-60.
17. Zhou J, Wang X, Du L, Zhao L, Lei F, Ouyang W, et al. Effect of hyperthermia on the apoptosis and proliferation of CaSki cells. Mol Med Rep. 2011;4(1):187-91.
18. McTaggart RA, Dupuy DE. Thermal ablation of lung tumors. Tech Vasc Interv Radiol. 2007;10(2):102-13.
19. Hiraki T, Gobara H, Fujiwara H, Ishii H, Tomita K, Uka M, et al. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30(2):169-75.
20. Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. J Exp Clin Cancer Res. 2015;34:22.
21. Ke S, Ding XM, Kong J, Gao J, Wang SH, Cheng Y, et al. Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma. J Transl Med. 2010;8:73.
22. Obara K, Matsumoto N, Okamoto M, Kobayashi M, Ikeda H, Takahashi H, et al. Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int. 2008;2(1):116-23.
23. Yao H, Wang H, Zhang Z, Jiang BH, Luo J, Shi X. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int J Cancer. 2008;123(6):1255-61.
24. Wan J, Che Y, Kang N, Wu W. SOCS3 blocks HIF-1alpha expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3. Mol Med Rep. 2015;12(1):83-92.
25. Jett JR, Carr LL. Targeted therapy for non-small cell lung cancer. Am J Respir Crit Care Med. 2013;188(8):907-12.
26. Inazu M, Yamada T, Kubota N, Yamanaka T. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Pharmacol Res. 2013;76:119-31.
27. Wan J, Wu W, Che Y, Kang N, Zhang R. Low dose photodynamic-therapy induce immune escape of tumor cells in a HIF-1alpha dependent manner through PI3K/Akt pathway. Int Immunopharmacol. 2015;28(1):44-51.
28. Gayed BA, O'Malley KJ, Pilch J, Wang Z. Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors. Clin Transl Sci. 2012;5(1):39-42.
29. Luo HY, Wei W, Shi YX, Chen XQ, Li YH, Wang F, et al. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines. Oncol Rep. 2010;23(6):1735-45.
30. Liu B, Kuang A. Genetic alterations in MAPK and PI3K/Akt signaling pathways and the generation, progression, diagnosis and therapy of thyroid cancer. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012;29(6):1221-5.
31. Heavey S, O'Byrne KJ, Gately K. Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. Cancer Treat Rev. 2014;40(3):445-56.
32. Ding M, Zhang E, He R, Wang X. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy. Cancer Sci. 2013;104(11):1401-10.
33. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One. 2011;6(4):e19139.
34. Chen Y, Tang Q, Wu J, Zheng F, Yang L, Hann SS. Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells. J Exp Clin Cancer Res. 2015;34:154.
35. Wang X, Shi W, Shi H, Lu S, Wang K, Sun C, et al. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. J Exp Clin Cancer Res. 2016;35(1):100.